Mathew Aby J. 4
4 · BIOLIFE SOLUTIONS INC · Filed Apr 11, 2025
Insider Transaction Report
Form 4
Mathew Aby J.
EVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-04-09$20.11/sh−569$11,443→ 309,007 total
Footnotes (1)
- [F1]The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.